EZZ Life Science Holdings Ltd Cash Flow-to-Debt Ratio
EZZ Life Science Holdings Ltd cash flow-to-debt ratio. EZZ Life Science Holdings Ltd (EZZ) has a Cash Flow-to-Debt Ratio of -1.15x as of December 2025, meaning its operating cash flow of AU$-5.50 Million could theoretically repay -1% of its total liabilities (AU$4.80 Million) in one year. Check EZZ Life Science Holdings Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of EZZ Life Science Holdings Ltd (2018–2024)
Cash flow-to-debt ratio of EZZ Life Science Holdings Ltd from 2018 to 2024. Historical debt coverage capacity for EZZ Life Science Holdings Ltd across 7 annual periods. Check EZZ Life Science Holdings Ltd (EZZ) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
EZZ Life Science Holdings Ltd Cash Flow-to-Debt Ratio by Year (2018–2024)
EZZ Life Science Holdings Ltd cash flow-to-debt ratio by year from 2018 to 2024. Year-by-year debt coverage analysis for EZZ Life Science Holdings Ltd. For the full cash flow conversion analysis, see EZZ Life Science Holdings Ltd (EZZ) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.74x | AU$4.35 Million | AU$5.87 Million | ▼ -49.0% |
| 2023 | 1.45x | AU$6.14 Million | AU$4.23 Million | ▲ +10.7% |
| 2022 | 1.31x | AU$4.01 Million | AU$3.06 Million | ▲ +98.6% |
| 2021 | 0.66x | AU$1.90 Million | AU$2.88 Million | ▲ +403.3% |
| 2020 | 0.13x | AU$253.53K | AU$1.93 Million | ▼ -83.3% |
| 2019 | 0.79x | AU$2.97 Million | AU$3.78 Million | ▲ +295.6% |
| 2018 | 0.20x | AU$416.33K | AU$2.09 Million | — |